Question explored with the scientific record
how to deal with constipation caused by taking . Will senna type laxatives help
The short version: senna will move stool, but it treats the symptom, not the cause, and carries risks with long-term use that nobody studying drug-induced constipation has adequately tracked.
The evidence shows that senna-type stimulant laxatives work on the mechanics. A 1997 study of 66 healthy adults found senna reduced whole-gut transit time from a median of 67 to 41 hours and nearly doubled stool output per week [2]. The Bristol Stool Form Scale shifted from 3.6 (normal) to 4.6 (softer) [2]. So yes, senna will produce a bowel movement.
But the question is why you are constipated. You did not name the medication, but the most common causes are opioids, certain blood pressure drugs, antidepressants, and iron supplements. Senna does not address the underlying mechanism. If it is an opioid, a 2016 patient survey of 198 chronic pain patients taking laxatives found 75% reported side effects and no improvement in constipation quality-of-life scores compared to those not using laxatives [5]. Laxatives failed these patients at the outcome that matters: how they felt.
There is also a long-term cost. A 2020 expert round-table warned that chronic use of stimulant laxatives like senna and cascara may cause pseudomelanosis coli, a discoloration of the colon wall, and noted potential neoplastic changes from older literature [1]. The warning was cautious, but it was stated. A Cochrane review on childhood constipation found polyethylene glycol (PEG, an osmotic laxative like MiraLax) outperformed placebo and most alternatives in stool frequency, and the evidence quality was still low [3]. That review also noted that stimulant laxatives like senna are not recommended for maintenance treatment [4].
For drug-induced constipation, the first step should be addressing the drug itself. If the drug cannot be changed, an osmotic laxative like PEG has better long-term safety data and comparable efficacy. Senna as a rescue therapy for 1-2 days is unlikely to cause harm. Senna taken daily for weeks or months is a different question.
| Approach | Effect on stool | Long-term safety data |
|---|---|---|
| Senna (stimulant) | Faster transit, softer stool [2] | Weak; possible colon changes with chronic use [1] |
| PEG (osmotic) | Increased frequency; better than placebo in children [3] | More data available; recommended in guidelines [4] |
| Treat underlying cause | Varies | Depends on the drug |
My call: senna works for acute relief, but the evidence does not support it as a safe long-term solution for drug-induced constipation, and the real answer lies in addressing the medication itself. Confidence: moderate - the short-term mechanics are well-documented, but the long-term risks in this specific context have not been adequately studied.
Sources used 5
-
Expert round-table Constipation: diagnosis, treatment, risks
Expert round-table discusses prevalence, diagnosis, treatment options, safety considerations for laxatives (notably stimulant laxatives), colorectal cancer risk, and the role of colonoscopy and lifestyle modifications in managing constipation.
DOI: 10.21518/2079-701x-2020-15-12-18 -
Stool Form Scale as a Useful Guide to Intestinal Transit Time
This study validates that the Bristol Stool Form Scale reliably tracks changes in whole-gut transit time in healthy adults and demonstrates that stool form changes closely mirror transit-time changes induced by senna or loperamide.
DOI: 10.3109/00365529709011203 -
Osmotic and stimulant laxatives for the management of childhood constipation
This systematic review evaluates the effectiveness and safety of osmotic and stimulant laxatives for managing childhood constipation, finding that polyethylene glycol (PEG) is generally more effective than placebo and other laxatives, though the evidence quality is low due to me…
DOI: 10.1002/14651858.cd009118.pub3 -
Pediatric Constipation Therapy Using Guidelines and Polyethylene Glycol 3350
A literature-based review comparing pediatric functional constipation guidelines and evaluating the efficacy, safety, and dosing of polyethylene glycol 3350 (PEG 3350) as maintenance and disimpaction therapy, with implications for clinical practice.
DOI: 10.1345/aph.1D297 -
Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey
A UK cross-sectional survey of 198 opioid-treated chronic pain patients shows that laxatives are widely used to treat opioid-induced constipation but do not improve constipation or quality of life and often cause side effects, highlighting the need for targeted treatments and be…
DOI: 10.1093/pm/pnw240